CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Off-label GLP-1 agonist treatment in 43 non-diabetic patients: Are weight loss and treatment tolerance equally promising outside of clinical trials?
DOI 10.1055/s-0033-1347764
Bibliografische Angaben
Nachweis in CareLit
Autor:innenN Sauer, C Schulze zur Wiesch, F Reining, Z Rohani, J Aberle
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe08/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Context: Recent data from controlled clinical trials have demonstrated that GLP-1 agonists are a well-tolerated therapy-option for weight loss in obese patients without type 2 diabetes mellitus. Objective: To investigate whether continuation of treatment, side-effects and effect on weight loss of GLP-1 agonists are equally promising in dairy clinical practice settings in non-diabetics. Methods: Obese, non-diabetic p…
Zitieren
Zitierempfehlung
N Sauer, C Schulze zur Wiesch, F Reining, Z Rohani, J Aberle (2013) Off-label GLP-1 agonist treatment in 43 non-diabetic patients: Are weight loss and treatment tolerance equally promising outside of clinical trials?. Diabetologie und Stoffwechsel (08). https://doi.org/10.1055/s-0033-1347764
Mit CareLit weiterarbeiten